BMO Capital Upgrades Alexion Pharmaceuticals (ALXN) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Alexion Pharma (ALXN) Misses Q1 EPS by 2c
April 28, 2016 6:35 AM EDTAlexion Pharma (NASDAQ: ALXN) reported Q1 EPS of $1.11, $0.02 worse than the analyst estimate of $1.13. Revenue for the quarter came in at $701 million versus the consensus estimate of $710.98 million.
For earnings history and earnings-related data on Alexion Pharma (ALXN) click here.
... More